Literature DB >> 2551656

Growth and secretory responses of enriched populations of corticotropes.

G V Childs1, J Lloyd, G Unabia, D Rougeau.   

Abstract

The purpose of this study was to learn whether enriched populations of corticotropes could be grown without the other pituitary cell types. Corticotropes populations were enriched to 80-90% by counterflow centrifugation in an elutriator with the Sanderson chamber. After initial separation into small, medium, and large fractions, the cells were stimulated for 3 h with 0.5 nM corticotropin-releasing hormone (CRH) and then re-eluted to remove the enlarged corticotropes. More ACTH (6- to 10-fold) was released in media with 10% fetal bovine serum (FBS) than was released in media with no serum. The effects of FBS could not be mimicked by 0.3% BSA. Corticotropes grew in serum-containing media as long as they were plated at a density of at least 2500 cells per well. The corticotropes expanded in size and assumed two major morphological subtypes. Both stored ACTH and beta-endorphin. One subtype was flattened and pleomorphic. The other subtype was stellate with multiple processes. Cell counts showed a 2.5- to 3.8-fold increase in the number of labeled corticotropes during the first 21 days of culture. Then the numbers of cells declined rapidly. Basal secretion of ACTH rose 1.6-fold during the first week, plateaued after 14 days and then declined to less than 30% of first week levels. CRH stimulation produced dose-dependent increases in media ACTH. In 7 day cultures, both basal and stimulated levels of ACTH were similar to those in 7 day cultures of mixed pituitary cells (containing equivalent numbers of corticotropes). Stimulatory effects of CRH were evident for up to 42 days of culture. Arginine vasopressin enhanced CRH-mediated secretion in most cultures in the first week. Pretreatment with glucocorticoids (100 nM corticosterone) for 15 h blocked CRH-mediated secretion in all cultures. The studies showed that corticotropes do not need the other pituitary cell types for basic plating and basal and CRH-mediated secretory responses. Further tests of specific growth factors are needed to learn whether they will maintain function for longer periods.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551656     DOI: 10.1210/endo-125-5-2540

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Corticotropin releasing hormone inhibits an inwardly rectifying potassium current in rat corticotropes.

Authors:  Y A Kuryshev; L Haak; G V Childs; A K Ritchie
Journal:  J Physiol       Date:  1997-07-15       Impact factor: 5.182

2.  A Sex-Dependent, Tropic Role for Leptin in the Somatotrope as a Regulator of POU1F1 and POU1F1-Dependent Hormones.

Authors:  Angela K Odle; Melody L Allensworth-James; Noor Akhter; Mohsin Syed; Anessa C Haney; Melanie MacNicol; Angus M MacNicol; Gwen V Childs
Journal:  Endocrinology       Date:  2016-08-29       Impact factor: 4.736

3.  A Serum-Free System for Primary Cultures of Human Pituitary Adenomas.

Authors:  Eleni Thodou; Lily Ramyar; Arthur I. Cohen; William Singer; Sylvia L. Asa
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

Review 4.  The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress.

Authors:  Greti Aguilera; Sivan Subburaju; Sharla Young; Jun Chen
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

5.  Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.

Authors:  S Akita; J Webster; S G Ren; H Takino; J Said; O Zand; S Melmed
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.